...
首页> 外文期刊>Annals of allergy, asthma, and immunology >Reproducibility of skin testing and serum venom specific IgE in Hymenoptera venom allergy.
【24h】

Reproducibility of skin testing and serum venom specific IgE in Hymenoptera venom allergy.

机译:在膜翅目毒液过敏中进行皮肤测试和血清毒液特异性IgE的可重复性。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: The decision regarding an immunotherapy regimen for venom-allergic patients is based on the results of skin testing and serum venom specific IgE measurements. However, their reliability has been questioned, and their reproducibility has not been examined. OBJECTIVE: To evaluate the reproducibility and reliability of the results of skin testing and serum venom specific IgE measurement in venom-allergic patients. METHODS: Patients with a systemic reaction after an insect sting were evaluated twice, 2 to 6 weeks apart, by intradermal skin tests and by determination of serum venom specific IgE to Hymenoptera venoms. RESULTS: Thirty-five patients were evaluated 1 to 168 months (mean, 23 months) after the sting reaction. Reproducibility of skin test results for all venoms at the 2 sessions was found in 23 patients (66%). Reproducibility of venom specific IgE results for all venoms was found in 16 (59%) of 27 patients from whom 2 blood samples were available for evaluation. Concordance between skin test and venom specific IgE results for all venoms was found in 30 (51%) of 59 samples available for evaluation. CONCLUSIONS: The reproducibility of venom skin test and serum venom specific IgE results is relatively poor. It is common practice for therapeutic decisions regarding venom immunotherapy to be based on a single diagnostic evaluation. Consequently, many patients are either overtreated or undertreated. Better diagnostic methods are required in venom allergy.
机译:背景:有关针对毒液过敏患者的免疫疗法的决定是基于皮肤测试和血清毒液特异性IgE测量的结果。但是,它们的可靠性受到质疑,并且其可重复性尚未得到检验。目的:评价皮肤试验和血清毒特异性IgE检测结果在毒液过敏患者中的可重复性和可靠性。方法:通过皮内皮肤试验和测定针对膜翅目毒液的血清毒特异性IgE,对两次被驱虫后全身反应的患者进行两次评估,间隔2至6周。结果:刺痛反应后1到168个月(平均23个月)评估了35例患者。在23个病人中(66%),发现在2个疗程中所有毒液的皮肤测试结果具有可重复性。在27例患者中有16例(59%)发现了针对所有毒液的毒液特异性IgE结果的可重复性,其中有2个血液样本可用于评估。在可用于评估的59个样本中,有30个(51%)发现了所有毒液的皮肤测试与毒液特异性IgE结果之间的一致性。结论:毒液皮肤试验和血清毒液特异性IgE结果的可重复性相对较差。关于毒液免疫疗法的治疗决策的通常做法是基于单个诊断评估。因此,许多患者要么治疗过度,要么治疗不足。毒液过敏需要更好的诊断方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号